Antithrombotic therapy at the end-of-life—continue or stop?
Antithrombotic therapy at the end-of-life—continue or stop? Gerard Gurumurthy 1,2;…
Ler MaisMulti-omics integration reveals molecular heterogeneity and constructs a machine learning survival model for sepsis-induced coagulopathy
Multi-omics integration reveals molecular heterogeneity and constructs a machine learning…
Ler MaisPatient adherence and satisfaction with self-administration of prophylactic Low Molecular Weight Heparin (LMWH) after orthopaedic trauma surgery: a prospective observational cohort study
Low Molecular Weight Heparin (LMWH) after orthopaedic trauma surgery Patient…
Ler MaisIdentifying the spectrum of clinical trajectories in intermediate-high risk pulmonary embolism: A clinical and research imperative
Identifying the spectrum of clinical trajectories in intermediate-high risk pulmonary…
Ler MaisEvolving biomarkers and risk prediction models in colorectal cancer-associated venous thromboembolism
Evolving biomarkers and risk prediction models in colorectal cancer-associated venous…
Ler MaisAbsolute quantitative proteomics identifies patterns of plasma proteins associated with venous thromboembolism in patients with colorectal cancer
Absolute quantitative proteomics identifies patterns of plasma proteins associated with…
Ler MaisMonitoring the Hemostatic Balance: measuring thrombin generation in a patient with acquired hemophilia A on combined pro- and anticoagulant therapy
Monitoring the Hemostatic Balance: measuring thrombin generation in a patient…
Ler Mais